Is pembrolizumab monotherapy the optimal treatment for elderly patients with PD-L1 positive advanced non-small cell lung cancer?

Detalles Bibliográficos
Autores principales: Mienko, Fiona, Halmos, Balazs, Cheng, Haiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333146/
https://www.ncbi.nlm.nih.gov/pubmed/32647703
http://dx.doi.org/10.21037/atm.2020.02.68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333146/
https://www.ncbi.nlm.nih.gov/pubmed/32647703
http://dx.doi.org/10.21037/atm.2020.02.68

Ejemplares similares